<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="94170">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02006355</url>
  </required_header>
  <id_info>
    <org_study_id>5560</org_study_id>
    <nct_id>NCT02006355</nct_id>
  </id_info>
  <brief_title>Continuous Local Anesthesia Versus Continuous Femoral Nerve Bloc After Total Knee Arthroplasty: Impact on Mean Discharge Aptitude Delay</brief_title>
  <acronym>GLASGOW</acronym>
  <official_title>Continuous Local Anesthesia Versus Continuous Femoral Nerve Bloc After Total Knee Arthroplasty: Impact on Mean Discharge Aptitude Delay</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims at comparing continuous local anesthesia and femoral nerve bloc for total
      knee arthroplasty in terms of post-operative recovery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">August 2017</completion_date>
  <primary_completion_date type="Anticipated">April 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Discharge ability time period</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 10 days</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Total Knee Arthroplasty</condition>
  <arm_group>
    <arm_group_label>Continuous femoral nerve bloc</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Continuous femoral nerve bloc</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Continuous local anesthesia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Continuous local infiltration of local anesthetic in the operated knee.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <arm_group_label>Continuous femoral nerve bloc</arm_group_label>
    <arm_group_label>Continuous local anesthesia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Total knee arthroplasty

          -  Age &gt; 18 years with social security covering.

          -  Written informed consent

        Exclusion Criteria:

          -  Age &lt; 18 years

          -  ASA Physical Status &gt; III

          -  Body weight &lt; 50 kg

          -  Latex or silver allergy.

          -  Loco-regional anesthesia contraindication

          -  Chronic anticoagulant, corticoid or pain treatment.

          -  Rivaroxaban or enoxaparin contraindication

          -  Communication issues

          -  Patient under guardianship

          -  Pregnant or breast-feeding patient
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Yves JENNY, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpitaux Universitaires de Strasbourg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jean-Yves JENNY, MD</last_name>
    <phone>03 88 55 24 56</phone>
    <phone_ext>+33</phone_ext>
    <email>jean-yves.jenny@chru-strasbourg.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CCOM-Hôpitaux Universitaires de Strasbourg</name>
      <address>
        <city>Illkirch</city>
        <zip>67400</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Yves JENNY, MD</last_name>
      <phone>03 88 55 24 56</phone>
      <phone_ext>+33</phone_ext>
      <email>jean-yves.jenny@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-Yves JENNY, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-François KEMPF, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cyril BOERI, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre DIEMUNSCH, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eric NOLL, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fatem-Zohra LAALOU, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nicolas ROBIAL, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jérémy BESSE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yann DIESINGER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julia BOUCHAIB, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Calin OLTEAN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 13, 2014</lastchanged_date>
  <firstreceived_date>November 27, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
